News
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...
Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...
Novo Nordisk A/S’s next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
THIS VIDEO CONTAINS CONTENT SOME PEOPLE MAY FIND DISTRESSING“There is this one kid who called me pregnant because of my ...
Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...
A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...
Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results